Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis

ConclusionsIn this real-world population of US patients with RA who had prior TNFi exposure, there was no evidence of a difference in the effectiveness of TCZ monotherapy compared with that of TNFi + MTX, regardless of MTX dose, at 6 months for improving RA disease activity.FundingCorrona, LLC.Plain Language SummaryPlain language summary available for this article.

http://link.springer.com/10.1007/s40744-018-0127-1

Source: Rheumatology and Therapy - October 6, 2018 Category: Rheumatology Source Type: research